JB Chemicals & Pharmaceuticals Ltd.
JBCHEPHARM Share PricePharmaceuticals & Drugs
₹1,729.1
3.9 (0.2%)
As on September 9, 2025
Exchange Scrips: BSE506943NSEJBCHEPHARMISININE572A01036
Market Cap ₹ 27,091 Cr
P/E Ratio 40.81
Dividend Yield 0.9 %
Performance
Market performance
Open1,722
High1,730
Volumes1,28,444
Prev1,729.1
Low1,713.3
As on2025-09-09
Historical performance
1 Year High1,984
3 Year High2,030
5 Year High2,030
1 Year Low1,385.75
3 Year Low875
5 Year Low393.02
Fundamentals
Company Valuation
Market Cap (₹Cr)
27,091
Face Value (₹)
1
P/E Ratio
40.81
Dividend Yield
0.9 %
Investment Returns
1 Year
-10.7%
3 Years
87.2%
5 Years
338.9%
10 Years
1204.5%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,724.98 | Bullish |
| 10-DMA | 1,721.55 | Bullish |
| 20-DMA | 1,722.99 | Bullish |
| 50-DMA | 1,695.84 | Bullish |
| 100-DMA | 1,680.55 | Bullish |
| 200-DMA | 1,696.66 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 70063 | 63947 | 62080 | 62742 | 66952 |
| Government | --- | --- | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 40.81.
- 3Y Stock Price CAGR of the stock is 22.7.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹10702 Million.
- The company generated revenue of ₹39180 Million in the previous financial year.
JB Chemicals & Pharmaceuticals Ltd.
1729.13.9 (0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 904270.1
No. of Shares: 523 (Approx)
Performance:-9.6%
P/L: ₹-95729.9
Top Gainers
| Symbol | Change% |
|---|---|
| ITDC | 653.6(20%) |
| LASA | 12.74(20%) |
| PRECAM | 254.93(16%) |
| JTEKTINDIA | 181.94(15%) |
| QUICKHEAL | 335.1(14%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent